ELISA診断検査市場規模・予測（2020年～2030年）、世界・地域シェア、動向、成長機会分析レポート対象範囲適応疾患別（ヒト、動物用）、検査タイプ別（サンドイッチELISA、間接ELISA、競合ELISA、マルチプル＆ポータブルELISA）、用途別（自己免疫疾患、感染症、がん診断、タンパク質定量、その他）、エンドユーザー別（病院・診断センター、製薬・バイオテクノロジー企業、動物病院・診断ラボ、その他）、地域別（北米、欧州、アジア太平洋、南米・中米、中東・アフリカ）

ELISA Diagnostic Test Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)

ELISA診断検査市場は、2022年の12億8549万米ドルから2030年には22億7123万米ドルに成長すると予測され、2022年から2030年までの年平均成長率は7.37%と推定される。市場発展の主な原動力は、動物間の感染症の増加... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Insight Partners ザ・インサイトパートナーズ	2023年11月2日	US$4,550 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	199	英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

ELISA診断検査市場は、2022年の12億8549万米ドルから2030年には22億7123万米ドルに成長すると予測され、2022年から2030年までの年平均成長率は7.37%と推定される。市場発展の主な原動力は、動物間の感染症の増加とヒト感染症の発生率の増加である。

酵素結合免疫吸着測定法（ELISA）は、患者の血液中の抗体を検出・測定する検査法である。この検査は、患者が特定の感染症に関連する抗体を持っているかどうかを判定するために使用できる。ELISA検査は、エイズを引き起こすHIV、ライム病、悪性貧血、ロタウイルスなどの診断に使用されます。ELISAキットは、サンプルや培養物中の特定のターゲットを迅速、簡便、正確に検出・定量できる貴重な研究ツールです。市販のELISAキットには、プレコートプレート、捕捉／検出抗体、標準品、緩衝液、その他必要な試薬が含まれています。各キットは、正確性、精度、感度、特異性、再現性を保証するために、厳格なバリデーションと安定性試験を受けています。

革新的な製品の上市がELISA診断検査市場にチャンスをもたらす。

ELISA法は、柔軟性、感度、使いやすさなど様々な利点があり、最も人気のある免疫測定法の一つである。また、ELISA検査キットの低コストとハイスループット検査に伴う多面的な適用性により、さまざまな研究やIVDの要件に理想的なソリューションとなっている。低コストの適用性により、検査キットの製品革新はヒトおよび動物研究の需要を高めている。また、メーカーは自社設備を備えたELISA検査キットの開発に注力している。

Innovative Research社は、凝固因子、生物種、抗体の同定に幅広い選択性を持つELISAキットを販売している。「ヒト血液凝固第IX因子キット」はその一例である。ヒト凝固第IX因子抗原アッセイは、ヒト血漿中の全IX因子抗原の定量を目的としています。このキットは研究目的にのみ使用することが推奨され、試薬は最大96の臨床検査に利用することができます。

さらに、COVID-19の大流行の中、各メーカーがELISA検査の革新的な製品を発売したことで、ELISA検査のヒトへの普及が加速している。

2022年12月、Pictor Limitedは「PictArray SARS-CoV-2抗体検査」の新製品発表を行った。この新製品は、COVID-19ウイルスに関連する感染を検出し、得られた臨床結果は、患者や医師がSARS-CoV-2感染症の治療や管理を行う際に役立ちます。メーカーによる革新的なELISA検査キットの発売は、低コストで多面的な応用が可能で、さまざまな生物種に関連する多様な感染症の診断に効果的な臨床結果を提供することが期待される。このように、革新的な製品の発売は、長期的にはメーカーに有利な機会を提供するだろう。

市場動向

ELISAベースの手順の進歩

ELISAを用いた体外診断（IVD）は、世界市場で大きな注目を集めている。さまざまな分野の研究者が、磁気ビーズ、紙ベースのプラットフォーム、ナノ材料などの技術を通じて、ELISAベースの手順の開発と応用に魅力を感じている。技術ベースのELISAキットの他の例としては、デジタルELISA、マルチプレックスELISA、単一分子ELISA、ナノ粒子ベースELISA、スマートフォンベースELISAなどがある。また、迅速かつ効率的な臨床結果を得るために、各社は複数の技術に基づくELISA検査キットを発売している。AMP'D ELISAシグナル増幅システム」は、Enzo Life Sciences, Inc.が製造している。AMP'Dテクノロジーは、1つの増幅キットでサンドイッチELISA検査タイプの感度を効率的に向上させ、高い感度を提供する。

Cell Signaling Technology, Inc.が設計した "PathScan Phospho-RSK1 (Ser380) Sandwich ELISA Kit "も、テクノロジーを駆使したELISA検査キット製品の一例である。このような高度な技術に基づくELISA検査キット製品は、獣医やヒトに関連する感染症や疾病の原因となる様々な種を検出するために、将来的に獣医師による高い需要が見込まれる。したがって、ELISAベースの手順の進歩は、2020～2030年のELISA診断検査市場の成長を強化すると予想される。

アプリケーションベースの洞察

アプリケーション別では、ELISA診断検査市場は自己免疫疾患、感染症、がん診断、タンパク質定量、その他に分類される。感染症セグメントは2022年に市場で最大のシェアを占め、2022-2030年の市場において最高のCAGR 8.43%を記録すると予測されている。ELISAは、免疫学において抗体や抗原を検出し、アレルギー検査や自己免疫疾患の診断を行うための強力な技術である。自己免疫疾患やウイルス性疾患（HIV、STI、B型肝炎など）の罹患率が高齢化、人口動態やライフスタイルの変化により世界中で増加していることが、世界のELISA診断検査市場の成長を牽引している。2023年にNational Stem Cell Foundationが発表した統計によると、自己免疫疾患は80種類以上の疾病に罹患しており、世界人口の4％近くが罹患している。最も一般的な自己免疫疾患は、1型糖尿病、多発性硬化症、関節リウマチ、ループス、クローン病、乾癬、強皮症などである。米国では、自己免疫疾患は慢性疾患の原因として3番目に多い。まれではあるが、これらの病気を合わせると、米国人口の5％から8％が罹患している。例えば、2022年5月にPubMed Centralで発表された論文によると、自己免疫性水疱症（AIBD）特異的抗体の従来の血清学的検出では、組織基質を用いた最初のスクリーニングに続いて、ELISAなどの抗原特異的アッセイが行われる。

さらに、次世代免疫診断プラットフォームの開発など、さまざまな技術的進歩が市場の成長を促進すると予想される。

検査タイプ別に見ると、サンドイッチELISA、間接ELISA、競合ELISA、マルチプル＆ポータブルELISAに分類される。2022年の市場シェアは間接ELISAが大きく、2022～2030年のCAGRは同セグメントが高いと予測される。

ELISA診断検査市場は、エンドユーザー別に、病院・診断センター、製薬・バイオテクノロジー企業、動物病院・診断研究所、その他に分類される。病院＆診断センターセグメントが2020-2030年の市場シェアで最大を占めた。

ページTOPに戻る

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
1.2.1 Global ELISA Diagnostic Tests Market – by Adoption
1.2.2 Global ELISA Diagnostic Tests Market – by Test Type
1.2.3 Global ELISA Diagnostic Tests Market – by Application
1.2.4 Global ELISA Diagnostic Tests Market – by End User
1.2.5 Global ELISA Diagnostic Tests Market – by Region
2. Executive Summary
2.1 Key Insights
2.2 ELISA Diagnostic Test Market, by Geography (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. ELISA Diagnostic Test Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 PEST Analysis
5. ELISA Diagnostic Test Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Rising Infectious Diseases Among Animals
5.1.2 Increasing Incidence of Human Infections
5.2 Key Market Restraints
5.2.1 Incidents of Product Recalls
5.3 Key Market Opportunities
5.3.1 Innovative Product Launches
5.4 Future Trends
5.4.1 Advancements in ELISA-Based Procedures
6. ELISA Diagnostic Tests Market - Global Market Analysis
6.1 ELISA Diagnostic Tests Market Revenue (US$ Mn), 2022 – 2030
7. Global ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – by Adoption
7.1 Overview
7.2 ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
7.3 Human
7.3.1 Overview
7.3.2 Human: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Veterinary
7.4.1 Overview
7.4.2 Veterinary: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8. Global ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – by Test Type
8.1 Overview
8.2 ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
8.3 Sandwich ELISA
8.3.1 Overview
8.3.2 Sandwich ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Indirect ELISA
8.4.1 Overview
8.4.2 Indirect ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Competitive ELISA
8.5.1 Overview
8.5.2 Competitive ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Multiple & Portable ELISA
8.6.1 Overview
8.6.2 Multiple & Portable ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9. Global ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – by Application
9.1 Overview
9.2 ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
9.3 Autoimmune Diseases
9.3.1 Overview
9.3.2 Autoimmune Diseases: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Infectious Disease
9.4.1 Overview
9.4.2 Infectious Disease: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Cancer Diagnosis
9.5.1 Overview
9.5.2 Cancer Diagnosis: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Protein Quantification
9.6.1 Overview
9.6.2 Protein Quantification: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10. Global ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – by End User
10.1 Overview
10.2 ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospitals & Diagnostic Centers
10.3.1 Overview
10.3.2 Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical & Biotechnology Companies
10.4.1 Overview
10.4.2 Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Veterinary Hospitals & Diagnostic Laboratories
10.5.1 Overview
10.5.2 Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11. ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – Geographic Analysis
11.1 North America: ELISA Diagnostic Tests Market
11.1.1 Overview
11.1.2 North America: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3 North America: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.1.4 North America: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.1.5 North America: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.1.6 North America: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.1.7 North America: ELISA Diagnostic Tests Market, by Country
11.1.7.1 US: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.1.1 Overview
11.1.7.1.2 US: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.1.3 US: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.1.7.1.4 US: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.1.7.1.5 US: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.1.7.1.6 US: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.1.7.2 Canada: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.2.1 Overview
11.1.7.2.2 Canada: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.2.3 Canada: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.1.7.2.4 Canada: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.1.7.2.5 Canada: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.1.7.2.6 Canada: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.1.7.3 Mexico: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.3.1 Overview
11.1.7.3.2 Mexico: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.3.3 Mexico: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.1.7.3.4 Mexico: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.1.7.3.5 Mexico: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.1.7.3.6 Mexico: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.2 Europe: ELISA Diagnostic Tests Market
11.2.1 Overview
11.2.2 Europe: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3 Europe: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.2.4 Europe: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.2.5 Europe: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.2.6 Europe: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.2.7 Europe: ELISA Diagnostic Tests Market, by Country
11.2.7.1 Germany: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.1.1 Overview
11.2.7.1.2 Germany: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.1.3 Germany: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.2.7.1.4 Germany: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.2.7.1.5 Germany: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.2.7.1.6 Germany: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.2.7.2 France: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.2.1 Overview
11.2.7.2.2 France: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.2.3 France: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.2.7.2.4 France: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.2.7.2.5 France: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.2.7.2.6 France: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.2.7.3 UK: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.3.1 Overview
11.2.7.3.2 UK: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.3.3 UK: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.2.7.3.4 UK: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.2.7.3.5 UK: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.2.7.3.6 UK: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.2.7.4 Italy: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.4.1 Overview
11.2.7.4.2 Italy: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.4.3 Italy: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.2.7.4.4 Italy: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.2.7.4.5 Italy: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.2.7.4.6 Italy: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.2.7.5 Spain: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.5.1 Overview
11.2.7.5.2 Spain: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.5.3 Spain: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.2.7.5.4 Spain: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.2.7.5.5 Spain: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.2.7.5.6 Spain: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.2.7.6 Rest of Europe: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.6.3 Rest of Europe: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.2.7.6.4 Rest of Europe: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.2.7.6.5 Rest of Europe: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.2.7.6.6 Rest of Europe: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.3 Asia Pacific: ELISA Diagnostic Tests Market
11.3.1 Overview
11.3.2 Asia Pacific: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3 Asia Pacific: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.3.4 Asia Pacific: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.3.5 Asia Pacific: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.3.6 Asia Pacific: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.3.7 Asia Pacific: ELISA Diagnostic Tests Market, by Country
11.3.7.1 China: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.1.1 Overview
11.3.7.1.2 China: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.1.3 China: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.3.7.1.4 China: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.3.7.1.5 China: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.3.7.1.6 China: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.3.7.2 Japan: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.2.1 Overview
11.3.7.2.2 Japan: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.2.3 Japan: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.3.7.2.4 Japan: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.3.7.2.5 Japan: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.3.7.2.6 Japan: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.3.7.3 India: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.3.1 Overview
11.3.7.3.2 India: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.3.3 India: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.3.7.3.4 India: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.3.7.3.5 India: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.3.7.3.6 India: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.3.7.4 Australia: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.4.1 Overview
11.3.7.4.2 Australia: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.4.3 Australia: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.3.7.4.4 Australia: ELISA Diagnostic Tests Market, by Test Type , 2020–2030 (US$ Million)
11.3.7.4.5 Australia: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.3.7.4.6 Australia: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.3.7.5 South Korea: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.5.1 Overview
11.3.7.5.2 South Korea: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.5.3 South Korea: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.3.7.5.4 South Korea: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.3.7.5.5 South Korea: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.3.7.5.6 South Korea: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.3.7.6 Rest of Asia Pacific: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.6.3 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.3.7.6.4 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.3.7.6.5 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.3.7.6.6 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.4 Middle East & Africa: ELISA Diagnostic Tests Market
11.4.1 Overview
11.4.2 Middle East & Africa: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3 Middle East & Africa: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.4.4 Middle East & Africa: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.4.5 Middle East & Africa: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.4.6 Middle East & Africa: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.4.7 Middle East & Africa: ELISA Diagnostic Tests Market, by Country
11.4.7.1 South Africa: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.1.1 Overview
11.4.7.1.2 South Africa: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.1.3 South Africa: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.4.7.1.4 South Africa: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.4.7.1.5 South Africa: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.4.7.1.6 South Africa: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.4.7.2 Saudi Arabia: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.2.1 Overview
11.4.7.2.2 Saudi Arabia: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.2.3 Saudi Arabia: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.4.7.2.4 Saudi Arabia: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.4.7.2.5 Saudi Arabia: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.4.7.2.6 Saudi Arabia: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.4.7.3 UAE: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.3.1 Overview
11.4.7.3.2 UAE: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.3.3 UAE: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.4.7.3.4 UAE: ELISA Diagnostic Tests Market, by Test Type , 2020–2030 (US$ Million)
11.4.7.3.5 UAE: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.4.7.3.6 UAE: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.4.7.4 Rest of Middle East & Africa: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.4.1 Overview
11.4.7.4.2 Rest of Middle East & Africa: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.4.3 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.4.7.4.4 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.4.7.4.5 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.4.7.4.6 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.5 South & Central America: ELISA Diagnostic Tests Market
11.5.1 Overview
11.5.2 South & Central America: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3 South & Central America: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.5.4 South & Central America: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.5.5 South & Central America: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.5.6 South & Central America: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.5.7 South & Central America: ELISA Diagnostic Tests Market, by Country
11.5.7.1 Brazil: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.1.1 Overview
11.5.7.1.2 Brazil: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.1.3 Brazil: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.5.7.1.4 Brazil: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.5.7.1.5 Brazil: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.5.7.1.6 Brazil: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.5.7.2 Argentina: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.2.1 Overview
11.5.7.2.2 Argentina: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.2.3 Argentina: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.5.7.2.4 Argentina: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.5.7.2.5 Argentina: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.5.7.2.6 Argentina: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
11.5.7.3 Rest of South & Central America: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.3.1 Overview
11.5.7.3.2 Rest of South & Central America: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.3.3 Rest of South & Central America: ELISA Diagnostic Tests Market, by Adoption, 2020–2030 (US$ Million)
11.5.7.3.4 Rest of South & Central America: ELISA Diagnostic Tests Market, by Test Type, 2020–2030 (US$ Million)
11.5.7.3.5 Rest of South & Central America: ELISA Diagnostic Tests Market, by Application, 2020–2030 (US$ Million)
11.5.7.3.6 Rest of South & Central America: ELISA Diagnostic Tests Market, by End User, 2020–2030 (US$ Million)
12. ELISA Diagnostics Test Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies in ELISA diagnostics test Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Bio-Rad Laboratories Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Idexx Laboratories Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Thermo Fisher Scientific Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Abbott Laboratories
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Danaher Corp
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Innovative Diagnostics SAS
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Pictor Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 DiaSorin SpA
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Elabscience Biotechnology Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Financial Overview
13.10.4 SWOT Analysis
13.10.5 Key Developments
13.11 Bio-Techne Corp
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms

ページTOPに戻る

Table of Contents

Summary

The ELISA Diagnostic Test Market is expected to grow from US$ 1,285.49 million in 2022 to US$ 2,271.23 million by 2030; it is estimated to register a CAGR of 7.37% from 2022 to 2030. Key driving factors behind the market development are the rising infectious diseases among animals and the increasing incidence of human infections are the key driving factors behind the market development.

An enzyme-linked immunosorbent assay (ELISA) is a test that detects and measures antibodies in a patient's blood. This test can be used to determine if the patient has antibodies related to certain infectious conditions. An ELISA test is used to diagnose HIV causing AIDS, Lyme disease, pernicious anemia, rotavirus, and among others. ELISA kits are a valuable research tool that offer quick, convenient, and precise detection and quantitation of specific targets in samples and cultures. Commercially available ELISA kits come with pre-coated plates, capture/detection antibodies, standards, buffers, and other necessary reagents. Each kit undergoes rigorous validation and stability testing to ensure accuracy, precision, sensitivity, specificity, and reproducibility.

Innovative Product Launches Creates Opportunities in ELISA Diagnostic Test Market.

ELISA is one of the most popular immunoassay tests owing to its various advantages such as flexibility, sensitivity, and easy-to-use features. Also, low cost of ELISA test kit and multifaceted applicability associated with high-throughput testing make it an ideal solution for various research and IVD requirements. With low-cost applicability, product innovations in the test kits enhance the demand for human and animal research. Also, manufacturers focus on developing ELISA test kits with in-house facilities.

Innovative Research company sells a wide range of ELISA kits with selectivity to a broad range in identifying coagulants, species, and antibodies. "Human Factor IX Kit" is one such example manufactured by Innovative Research. The human coagulation Factor IX antigen assay is intended for the quantitative determination of total Factor IX antigen in human plasma. The kit is recommended to use only for research purposes, and reagents can be utilized for up to 96 clinical tests.

Additionally, innovative product launches for ELISA tests by the manufacturers amid the COVID-19 pandemic accelerate the adoption of ELISA testing among humans.

In December 2022, Pictor Limited announced a new product launch of the "PictArray SARS-CoV-2 Antibody Test," which has demonstrated real clinical utility intended for patients and doctors. The new product detects the infection associated with the COVID-19 virus, and the clinical results produced assist the patients and doctors in treating and managing SARS-CoV-2 infection. Launches of innovative ELISA test kits by manufacturers are expected to provide effective clinical results for diagnosing varied infections associated with different types of species with low cost and multifaceted applications. Thus, innovative product launches would provide lucrative opportunities for manufacturers in the long run.

Market Trend

Advancements in ELISA-Based Procedures

The use of ELISA for in-vitro diagnostics (IVD) has gained considerable attention in the global market. Researchers from various fields have been attracted to the development and application of ELISA-based procedures through techniques such as magnetic beads, paper-based platforms, and nanomaterials. Other examples of technology-based ELISA kits are digital ELISA, Multiplex ELISA, Single-Molecule ELISA, Nanoparticle-Based ELISA, and Smartphone-Based ELISA. Also, companies launch ELISA testing kits based on several techniques for fast and efficient clinical results. The "AMP'D ELISA Signal Amplification system" is manufactured by Enzo Life Sciences, Inc. The AMP'D Technology efficiently improves the sensitivity of sandwich ELISA test type with a single amplification kit and offers high sensitivity.

Cell Signaling Technology, Inc.'s "PathScan Phospho-RSK1 (Ser380) Sandwich ELISA Kit," designed by Cell Signaling Technology, is another example of a technology-advanced ELISA test kit product. Such advanced technology-based ELISA test kit products will have a high demand in the future by veterinarians for the detection of different species responsible for veterinary and human-associated infections or diseases. Therefore, advancements in ELISA-based procedures are expected to bolster the ELISA diagnostic test market growth during 2020–2030.

Application-Based Insights

In terms of Application, the ELISA Diagnosis Test Market is categorized into autoimmune diseases, infectious disease, cancer diagnosis, protein quantification, and others. The infectious disease segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR of 8.43% in the market during the 2022-2030. ELISA is a powerful technique in immunology for detecting antibodies and antigens and performing allergy testing and autoimmune disease diagnosis. The growing incidence of autoimmune diseases, and viral diseases (HIV, STI, hepatitis B, and others) across the world owing to the aged population and changes in demographics and lifestyle is driving the growth of the global ELISA diagnostic testing market. As per the statistics given by National Stem Cell Foundation in 2023, autoimmune diseases affect more than 80 different types of diseases and nearly 4% of the world's population. The most common autoimmune diseases include type 1 diabetes, multiple sclerosis, rheumatoid arthritis, lupus, Crohn's disease, psoriasis, and scleroderma. In the United States, autoimmune diseases are the third most common cause of chronic illness. Although rare, collectively, these diseases affect between 5% and 8% of the US population. For instance, according to an article published by PubMed Central in May 2022, conventional serological detection of Autoimmune bullous disease (AIBD) specific antibodies involves an initial screening using tissue substrates, followed by an antigen-specific assay such as ELISA.

Moreover, various technological advancements, such as the development of next-generation immunodiagnostics platforms, are anticipated to drive the market growth.

Based on test type, is segregated as sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held a larger market share in 2022 and the same segment is anticipated to register a higher CAGR during 2022-2030.

The ELISA diagnostic test market, by end user, is categorized as hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospital & diagnostic laboratories, and others. The hospital & diagnostic centers segment held the largest share of the market during 2020-2030.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（バイオ薬物）の最新刊レポート

The Insight Partners 社の最新刊レポート

本レポートと同じKEY WORD（america europe）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（バイオ薬物）の最新刊レポート

The Insight Partners 社の最新刊レポート

本レポートと同じKEY WORD（america europe）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?